Workflow
中医药
icon
Search documents
第八届“一带一路”中医药发展论坛 第三届OTC品牌大会在杭召开
Zhong Guo Jing Ji Wang· 2025-11-27 02:55
11月25日-26日,"第八届'一带一路'中医药发展论坛暨第三届OTC品牌大会"在杭州举行。大会由中国非 处方药物协会、"一带一路"中医药发展论坛秘书处主办,浙江省医药行业协会、上海市食品药品安全研 究会联合主办。 本届大会汇聚了专家学者、国际代表、优秀企业家、媒体代表,为中医药发展与OTC品牌建设提供可落 地的品牌促进与国际化解决方案,通过深度交流共促健康行业高质量发展。 十二届全国政协副秘书长、教科文卫体委员会副主任张秋俭致辞表示,"一带一路"中医药的发展论坛已 成功举办八届,为推动中医药高质量融入"一带一路"建设,服务全球卫生健康事业,增进世界人民福祉 作出了重要贡献。她强调,"一带一路"上的中医药发展及OTC品牌发展,需进一步聚焦"做什么、怎么 做"的问题。中医药+OTC在"一带一路"平台实现世界共享,制定国际标准是关键,核心在于保障安全、 有效,最终实现中医药智慧与OTC品牌的高质量发展,为医药健康产业的发展进一步指明方向,打开更 多发展机遇的窗口。 中国非处方药物协会会长刘沛致辞指出,中医药及OTC行业肩负高质量发展使命,医药行业应坚持创新 驱动与国际化道路,让中国品牌"立起来、走出去"。国家标准 ...
诊疗人次增超1倍,山东“十四五”让中医药便民可及
Qi Lu Wan Bao· 2025-11-26 22:51
11月25日,山东省政府新闻办举行新闻发布会,邀请山东省卫生健康委主要负责同志等介绍"十四五"时 期山东全面推进健康山东建设情况。 山东省卫生健康委员会副主任、山东省中医药管理局副局长李明介绍,"十四五"时期,山东聚焦提升中 医药服务能力和水平,高质量建设国家中医药综合改革示范区,实施中医药振兴发展重大工程,加快推 动中医药高质量发展。截至2024年底,全省每千人口公立中医类医院床位数0.78张,每千人口中医执业 (助理)医师数0.8人,中医总诊疗人次1.27亿,较"十三五"末分别增长25.81%、53.85%和103.49%,中 医药传承创新发展跑出"加速度"。 中医医疗资源布局更加优化。获批建设国家中医疫病防治基地、国家中医康复中心各1处、中医类国家 区域医疗中心项目3个,建成省级区域中医医疗中心9家,优质医疗资源进一步扩容。省、市、县均建成 政府办中医类医院,二级以上政府办综合医院、妇幼保健院、传染病医院全部设置中医类临床科室,乡 镇卫生院和社区卫生服务中心中医药综合服务区实现全覆盖,贯通城乡的中医药服务网络越织越密。 中医药服务能力持续增强。创建国家中医优势专科48个,建成齐鲁中医药优势专科集群28个 ...
第八届“一带一路”中医药发展论坛、第三届OTC品牌大会在杭州召开
Zhong Guo Jing Ji Wang· 2025-11-26 08:49
Core Viewpoint - The "8th Belt and Road Traditional Chinese Medicine Development Forum and the 3rd OTC Brand Conference" aims to promote the high-quality development of the health industry through dialogue and collaboration among various stakeholders in the OTC and traditional Chinese medicine sectors [1][3]. Group 1: Conference Overview - The conference gathered representatives from "Belt and Road" countries, international organizations, regulatory bodies, industry experts, and media to create a dialogue platform for deep integration in the pharmaceutical and health sectors [3][7]. - The event focused on the innovative development of traditional Chinese medicine and the upgrading of OTC brands, providing actionable paths for brand cultivation and international practices [3]. Group 2: Key Speeches and Insights - The President of the China Non-Prescription Drug Association emphasized the importance of OTC as a vital part of the health service system, advocating for innovation-driven international development of Chinese brands [4]. - The Chairman of the Global Self-Care Federation highlighted China's significant role in strengthening global self-care systems and expressed a willingness to deepen cooperation with Chinese counterparts [4]. - Industry leaders discussed the transformation of consumer health markets and the importance of adapting traditional cultural symbols into globally recognized health values [5]. Group 3: Standards and Initiatives - The conference saw the release of the group standard for "Brand Value Evaluation of Non-Prescription Drug Enterprises," aimed at guiding the development of OTC brands and enhancing overall industry competitiveness [6]. - A new health education project titled "National 'Medicine' Health" was launched, designed to make professional medical knowledge accessible and engaging for the general public [6].
我省发布“十四五”时期健康山东建设成果 80.5岁!山东人均预期寿命再提高
Da Zhong Ri Bao· 2025-11-26 01:05
"我们加快拓展医疗服务供给,全省医疗卫生机构发展到9.01万家,卫生人员增加至118.13万人, 较"十三五"末分别增长6.11%和14.8%。"马立新介绍,山东完善以基层为重点的分级诊疗体系,医疗卫 生服务质效全面提升,"15分钟健康服务圈"整体形成,人民群众看病就医更加方便。 山东加快中医药传承创新发展,中医药在维护和促进人民健康中的作用更好发挥。突出创新赋能, 在全国首批获批建设国家中医药综合改革示范区,实施两批75个"揭榜挂帅"改革项目,推进中医药振兴 发展重大工程,获批国家中医药传承创新发展试验区等一系列试点示范,建成国家中医药传承创新中心 等一大批高层次平台,中医药高质量发展内生动力持续增强。 11月25日,省政府新闻办召开新闻发布会,介绍"十四五"时期我省全面推进健康山东建设有关情 况。省卫生健康委党组书记、主任,省中医药管理局局长马立新表示,"十四五"以来,全省卫生健康系 统履行服务人民健康职责,持续深化医药卫生体制改革,全面提升服务能力水平,人民群众享有健康服 务的公平性、可及性和质效性不断增强,2024年,全省人均预期寿命达到80.5岁,较"十三五"末提高了 1.4岁;孕产妇、婴儿死亡率分 ...
“我是股东”走进昆药集团:解码中医药企业的创新发展与战略蓝图
Quan Jing Wang· 2025-11-26 00:32
Core Insights - The event "I am a Shareholder - Visiting Listed Company Kun Pharmaceutical Group" showcased the company's innovative path, strategic layout, and industrial upgrade achievements, emphasizing its status as a top 100 pharmaceutical enterprise in China [1] Group 1: Cultural Heritage and Innovation - Investors experienced an immersive journey into traditional Chinese medicine culture at Kun Pharmaceutical's subsidiary Kun Traditional Chinese Medicine's museum and intangible cultural heritage experience center, highlighting the company's 640-year development in Yunnan [2] - The museum displayed historical documents, traditional pharmaceutical tools, and local medicinal materials, illustrating Kun Traditional Chinese Medicine's resource advantages in producing high-quality national medicines [2] - The integration of traditional craftsmanship with smart manufacturing was demonstrated, showcasing the preservation of traditional essence while enhancing production efficiency [2] Group 2: Strategic Dialogue and Industry Upgrades - The event featured a dialogue with key executives, including the Secretary-General of the Yunnan Listed Companies Association, emphasizing Kun Pharmaceutical's role as a representative of China's pharmaceutical industry transformation [3] - The company has developed a diversified business structure encompassing traditional Chinese medicine, chemical drugs, and pharmaceutical distribution, with a focus on health products for the aging population [3] Group 3: Investment Focus Areas - Investors expressed interest in three main areas: the silver economy, collaboration with China Resources Sanjiu, and globalization strategies [3] - Kun Pharmaceutical aims to deepen the "medical-nursing integration" model to cater to the growing elderly health market, enhancing product competitiveness through scientific research and rational medication guidance [3] - The company is accelerating its internationalization process, leveraging its global network resources, particularly in artemisinin, and has established sales networks in 60 countries [3] Group 4: Growth Potential and Resilience - An investor noted that Kun Pharmaceutical's strategic layout is both pragmatic and forward-looking, aligning with national policies and market demands, showcasing strong growth potential and resilience [4] Group 5: Conclusion - The event fostered a bridge of trust between industry and capital, highlighting Kun Pharmaceutical's goal of becoming a leader in the silver health industry while advancing its strategic blueprint for high-quality development in China's pharmaceutical sector [5]
2025长三角健康大会共绘中医药协同发展新篇章
Xin Hua Ri Bao· 2025-11-25 23:51
Core Insights - The 2025 Yangtze River Delta Health Conference aims to promote high-quality development in health and wellness in the region, aligning with national strategies for "Healthy China" and regional integration [1][2][3] Group 1: Conference Overview - The conference is themed "Co-construction and Sharing, Inheritance and Innovation," focusing on collaborative health development and the promotion of traditional Chinese medicine (TCM) [1][2] - The event is organized by various health and media organizations, highlighting the importance of TCM as a unique health resource and economic asset [1][2] Group 2: Keynote Addresses and Insights - Notable speakers, including Chinese Academy of Engineering member Zhang Boli, emphasized the significance of TCM in modern health services and its role in achieving a "Healthy China" [2][3] - The conference highlighted the need for institutional alignment in regional cooperation and the integration of TCM into modern health systems [3] Group 3: Innovation and Collaboration - The conference facilitated the signing of several key TCM research projects, marking a significant step in translating research into clinical applications [4] - A collaborative mechanism for the inheritance of traditional TCM skills was established, aiming to integrate resources and cultivate talent in the region [4] Group 4: Publications and Academic Exchange - The launch of the book "The Health Code in Medicinal Paste" aims to make TCM knowledge accessible to the public, promoting understanding and benefits of TCM practices [5] - The conference also initiated the 2025 Jiangsu Province TCM Academic Annual Conference, fostering further academic exchange [5] Group 5: Industry Participation and Innovations - The event showcased a diverse range of industry leaders and innovations, including companies like Kangyuan Pharmaceutical and Huazhong Sanjiu, highlighting a complete industry chain from drug development to specialized medical foods [7] - The conference featured a technology transfer area where innovative TCM products were presented, demonstrating the transition from traditional remedies to modern healthcare solutions [7]
中医养生大会在泰州开幕 “智慧养生”融入长三角
Xin Hua Ri Bao· 2025-11-25 21:46
江苏省中医养生学会会长、江苏省中西医结合医院主任中医师王佩娟表示,智慧养生旨在推动中医养生 理论与现代科技深度融合,探索更高效、更便捷、更个性化的健康服务模式。江苏省医学会会长王咏红 分享了全球医疗AI应用案例,剖析我国在数据壁垒、临床融合等领域的挑战,提出构建人机协同诊疗 模式及数字孪生医疗生态的愿景。中国人民解放军东部战区总医院干部保健科主任医师、海军军医大学 教授郑大东围绕科学养生原则展开分享,内容涵盖我国人口健康状况变迁、亚健康状态识别、疾病认知 误区及保健策略等。江苏省名中医、南京中医药大学党委常委、副校长周恩超从中医经典理论出发,阐 述了肾气在人体健康中的根本地位及实用调养方法。 据了解,本次大会精心设置了学术大会、专题分论坛以及中医药展示交易会三大部分。学术大会聚焦学 术前沿,分享最新研究成果和发展趋势。分论坛围绕特定领域进行深入研讨,而中医药展示交易会搭建 了"产学研用"合作的广阔平台,展示最新技术和产品。大会设立八个分论坛,覆盖顺时养生、肿瘤患者 体重管理、骨健康等专题,几乎囊括了中医养生的所有热点领域。 □ 本报记者赵晶 11月22日,2025中医养生大会暨江苏省中医养生学会第二次学术年会 ...
聚焦澳门特区施政报告:琴澳一体化加速,推进创新产业园建设
Nan Fang Du Shi Bao· 2025-11-25 17:28
Core Viewpoint - The Macau SAR government is actively promoting the development of the Hengqin Guangdong-Macau Deep Cooperation Zone, with significant progress made in the past year and plans for further integration and development by 2026 [1][9]. Group 1: Government Initiatives - In 2025, the Macau SAR government established a leadership group to enhance participation in the cooperation zone's development [1]. - The government aims to strengthen coordination and focus on key tasks, emphasizing the "Macau + Hengqin" strategic positioning [1][9]. - A legal task force was formed to facilitate Macau residents' living and working in the cooperation zone by modifying relevant laws and regulations [2]. Group 2: Infrastructure and Services - The cooperation zone has launched a cross-border school bus service for students, implementing a "no disembarkation" customs check model [2][5]. - The Macau International Airport's Hengqin cargo station is under construction, aiming to establish a new logistics hub for the region [5][9]. - A point-to-point emergency medical transfer service between hospitals in Macau and Hengqin has been established to enhance healthcare services [8]. Group 3: Economic Development - Over 180 key enterprises have registered in the cooperation zone, with a focus on attracting quality pharmaceutical companies [5][11]. - The cooperation zone is working on projects like the China-Portuguese (Spanish) Economic and Trade Service Center and the Hengqin International Education City [5][9]. - The government plans to promote the cooperation zone as a "world-class tourist resort" and enhance the "Macau-Hengqin Exhibition" brand [11]. Group 4: Employment and Talent Development - A youth employment support system is being established to facilitate job opportunities for Macau youth in the cooperation zone [11]. - The cooperation zone will enhance vocational training systems and establish a public training center for high-skilled talent [11]. Group 5: Policy and Regulatory Framework - The government is optimizing the management system and enhancing operational efficiency within the cooperation zone [12]. - There are plans to improve statistical systems and conduct joint surveys to better understand the needs of residents in both regions [12].
第八届“一带一路”中医药发展论坛:将“太极IP”打造为世界健康符号
Zhong Guo Xin Wen Wang· 2025-11-25 13:53
Core Insights - The eighth "Belt and Road" Traditional Chinese Medicine Development Forum and the third OTC Brand Conference will be held in Hangzhou from November 24 to 26, 2025, focusing on the internationalization of traditional Chinese medicine, brand building, and industrial innovation paths [1] Group 1: Company Overview - China National Pharmaceutical Group (China National Pharmaceutical Tai Chi) is a leading enterprise in the traditional Chinese medicine industry, invited to present at the conference with a speech titled "Tai Chi IP: From Chinese Corporate Symbol to Global Health Symbol" [3] - The company has accumulated significant brand assets, including three century-old enterprises, two time-honored brands, six items of intangible cultural heritage, and 1,317 registered trademarks domestically and internationally [4] Group 2: Brand Development Strategy - The company aims to transform "Tai Chi IP" into a unique global health symbol through a systematic strategy involving brand strategy, culture, recognition, communication, experience, and management [7] - The strategic path includes establishing a differentiated communication matrix for the mother brand, sub-brands, and a "4+1 pipeline" brand to promote a nationwide Tai Chi fashion trend [7] Group 3: International Expansion - As one of the "National Traditional Chinese Medicine Service Export Bases," the company has upgraded from "product export" to "service and model export," with over 30 product specifications entering more than 20 countries and regions, achieving nearly 100 overseas registration numbers and doubling export sales [8] - The company plans to build an international technological innovation system tailored to traditional Chinese medicine, integrating traditional theories and modern clinical efficacy to promote Tai Chi culture globally [8] Group 4: Awards and Recognition - At the conference, the company received multiple honors, with its core products ranking first in various categories of the "2025 Annual Comprehensive Statistics Ranking of Non-Prescription Drug Products" [8] - The company aims to continue promoting high-quality development in the traditional Chinese medicine industry, aspiring for "Tai Chi IP" to become a health symbol connecting tradition with modernity and China with the world [10]
陈李济:以陈皮为媒 老字号激活发展新动能
Ren Min Wang· 2025-11-25 09:50
Core Insights - The company launched the "Chenpi Culture Festival" in Guangzhou, themed "Sailing Against the Wind, Living Forever," and released the "Chenpi Health '14th Five-Year' Strategic Plan" [1] - The company has established a solid industrial barrier by leveraging authentic resources from the core production area in Jiangmen, Guangdong [1] - The company has developed a variety of products around the Chenpi health industry, including aged Chenpi, Chenpi tea, medicinal pastes, and health foods to meet diverse consumer needs [1] Group 1 - The company has created a GAP demonstration planting base in the core production area, ensuring the authenticity and quality stability of raw materials through standardized management [2] - The company combines traditional aging techniques with modern technology, establishing a digital platform for the Chenpi industry park in collaboration with China Telecom, enabling real-time data access via blockchain [2] - The company aims to transform "data elements" into "gold elements" for farmers' income through blockchain traceability and AI identification of aging levels [2] Group 2 - The company has introduced the "Changsheng" cultural IP to engage young people with traditional Chinese medicine through immersive activities [2] - The Chen Li Ji Traditional Chinese Medicine Museum in Guangzhou serves as a cultural hub, offering innovative products like Chenpi coffee and health teas [2] - The company actively promotes the integration of the Chenpi industry with cultural tourism, enhancing local dining and accommodation sectors through events at the Chenpi Culture Festival [2]